Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
R•••• H••••••••• C•••••• M••••••••• L••
R•••• H••••••••• Capital Partners is a private equity investment firm investing in lower and middle market companies in the healthcare service sector.
- Class
- Buyout firmprobable, confidence 80%
- Basis
- own website statement
- Size band
- Lower middle marketdefined by: proxy: $0.70bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
Classification history (3)
- Sep 16, 2026Buyout firm (probable, 80%, cls-pe-2)own website statement“R•••• is a private equity fund exclusively focused on healthcare services.”r•••••••.com
- Sep 16, 2026Buyout firm (probable, 80%, cls-pe-2)own website statement“R•••• is a private equity fund exclusively focused on healthcare services.”r•••••••.com
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 5 of 5 distinct vehicles are sworn Private Equity Funds; 5 reported gross assets on a filing in 2022 or later
- Adviser type
- registered investment adviser
- Form ADV filings
- Mar 16, 2018 to Mar 27, 2024
- RAUM
- $704Mregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 5
- PE fund GAV, latest filing
- $704Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $704Mevery private fund type, latest filing
- 2024 PE fund GAV
- $704Msum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-27, latest gav Private Equity Fund $704M, latest counts Private Equity Fund 5, lifetime distinct Private Equity Fund 5
- Employees
- 19
- Headquarters
- New York, NY
- Office address
- ONE PENN PLAZA, SUITE 4610, New York, NY, 10119
- Business phone
- (212)-393-4790
- Sectors
- healthcare
- Geography
- not stated or not yet read
- Revenue
- $20.0M to $100M
- EBITDA
- $2.0M to $10.0M
- Enterprise value
- not stated or not yet read
- Equity check
- $30.0M to $70.0M
- Control
- control
- Thesis
- We partner with leading entrepreneurs in fragmented sectors of healthcare where we believe we can provide a combination of operational expertise and financial backing to accelerate growth.
- roles
- unknown 14
- period
- to unknown, from unknown, undated holdings 14, dated observations 0
- window
- last unknown, first unknown
- control
- unknown 14
- companies
- 14
- geography
- investments
- 14
- seller kinds
- transactions
- 0
- cadence by year
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 11
- disclosed value usd
- n 0
- sector distribution
- count 10, share 0.714, value healthcare services, examples Autism Services, Dermatology Services, Dental Services, Non-Medical Home Care, count 1, share 0.071, value business services, examples H••••••••• Staffing
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 4, share 0.286, value outpatient mental health substance, examples Autism Services, Mental Health Services, Outpatient Services, Psych Crisis Services, count 2, share 0.143, value outpatient specialty clinics, examples Dermatology Services, Fertility Services, count 2, share 0.143, value home health, examples Non-Medical Home Care, In-Home H•••••••••, count 1, share 0.071, value staffing, examples H••••••••• Staffing, count 1, share 0.071, value dental, examples Dental Services, count 1, share 0.071, value optometry, examples Eyecare Services
14 companies on the graph (0 transactions); most in healthcare services (10); no dated observations
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| R•••••••• L• ADV: Private Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $220M as of Mar 27, 2024 | no Form D | Unknown | |
| R••••••• Q•• L• ADV: Private Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $187M as of Mar 27, 2024 | no Form D | Unknown | |
| R••••••• L••• ADV: Private Equity Fund | buyout or unlabelled | 2020 first reported on Form ADV | $83.8M as of Mar 27, 2024 | no Form D | Harvest | |
| R•••••• Q•• L••• ADV: Private Equity Fund | buyout or unlabelled | 2020 first reported on Form ADV | $81.9M as of Mar 27, 2024 | no Form D | Harvest | |
| R•••• H••••••••• C•••••• P•••••••• L••• ADV: Private Equity Fund | Buyout fund | unknown | $131M as of Mar 27, 2024 | no Form D | Unknown | |
| R•••• H••••••••• F••• I• | buyout or unlabelled | unknown | unknown | no reporting | no Form D | Unknown |
| R•••• H••••••••• F••• I•• | buyout or unlabelled | unknown | unknown | no reporting | no Form D | Unknown |
- D•••• C••••• K•• · Co-Managing Member · since Feb 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- D•••• C••••• K•• · MD, MBA Co-Founder & General Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- J••••••• C•••• · CEO · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- S•••• A•••• · DDS Co-Founder + CEO · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- T•••• K• W••• · Member · since Jan 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- H•••• C••••••• · Vice President · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- I•••• W••••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- D••••• L••• · Analyst · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- B•••• D•••• · General Counsel · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- J•• E••••• S••••••• · Chief Compliance Officer · since Feb 1, 2018 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- Jul 7, 2026R•••• H••••••••• C•••••• P••••••• Closes Fund IV Above Target at $610 Million
- Mar 31, 2026R•••• H••••••••• C•••••• M••••••••• L••: Private Equity Funds on Form ADV 5 (2024 extract) -> 8 (roster 2026-09-01)
- Nov 14, 2023R•••• H••••••••• Selected by Inc. Magazine as a Founder-Friendly Investment Firm for Second Consecutive Year
- Nov 11, 2022R•••• H••••••••• Selected by Inc. Magazine as a Founder-Friendly Investment Firm
- Nov 22, 2021R•••• H••••••••• C•••••• P••••••• Closes $415 Million Fund III at Hard Cap
- Jul 26, 2021Thriveworks Partners with Wellington Management
- Jul 26, 2021D•••••365 To Be Acquired by The Jordan Company, L.P.
- Mar 16, 2018R•••• H••••••••• C•••••• M••••••••• L•• first filed Form ADV in the extract (ERA)
R•••• H••••••••• C•••••• M••••••••• L•• is the same institution as 3 records in Venture Capital, Independent Sponsors and RIA and Wealth.
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…